Testosterone supplementation for “low T” is not supported by evidence, review concludes
BMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i5166 (Published 22 September 2016) Cite this as: BMJ 2016;354:i5166- Michael McCarthy
- Seattle
Evidence from randomized controlled trials does not support the use of testosterone supplementation for the treatment of symptoms often ascribed to low testosterone concentrations or “low T,” a systematic review has found.1
Adriane Fugh-Berman, of Georgetown University Medical Center in Washington, DC, who led the new study, said that the findings indicated that testosterone products were being marketed for many symptoms that were, in fact, part of normal ageing. “Testosterone has known risks and no clear benefits and shouldn’t be used by men with intact testicles,” Fugh-Berman said. …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£33 / $40 / €36 (excludes VAT)
You can download a PDF version for your personal record.